One-Liner
A consumer app that scans cosmetics ingredient labels against a user's personal allergen profile (built from dermatology patch test results), surfacing incompatible products at the point of purchase.
AI Thinking Process
Verb Transplant engine: 'underwrite' from insurance applied to cosmetics — consumer pays a small fee, gets a personal underwriting opinion on whether a product matches their allergy profile.
Product: personal allergy-profile app for women 25–50 with confirmed contact dermatitis. User scans product label, app matches against personal allergen list including chemical naming variants.
G002: Skincarisma, INCIDecoder, Yuka, Think Dirty, EWG Skin Deep. None found to match against a personal allergen list from patch test results. Gap appears real.
Drop dermatologist data dependency. Pivot: user-managed allergen profile entered manually or photographed from patch test paper. Removes HIPAA/GDPR friction point.
WHO: dermatology-confirmed allergic women, US/EU/JP, with previous patch test results. CURRENT: paper wallet card + Google + manual INCI scanning. WHY-SURPRISED: AI ingredient OCR + variant-naming reconciliation is 2024+ capability not found in existing consumer apps.
Pass 1 survival at 40% conviction. Biggest worry: subscription churn after user memorizes their 5–10 trigger ingredients.
CosMe App (allergylife.com.au) — built by dermatologists from Skin Health Institute. Described as evidence-based, tailor-made for Allergic Contact Dermatitis, with personalized recommendations based on each user's allergen profile. Exactly the product. Also found Soosee.app (label scanning) and EczemaWise (NEA-funded free tracking).
CosMe App by Skin Health Institute (a clinical research organization with patch-test trial credibility) is the exact product with a structural credentialing moat. The 'no consumer app does personal-profile matching' claim was factually wrong. FEATURE gate also fails — Skin Health Institute's dermatologist clinic-referral channel is moated in a way no startup can replicate.
Kill Reason
CosMe App by the Skin Health Institute (Australia) is the exact product — built by dermatologists, distributed through the Allergy Life patient network, with patch-test clinical trial provenance a startup cannot replicate. The claim that no consumer app does personal-profile matching from patch tests was factually wrong as of 2025–2026.
Risk Analysis
Risk analysis available for latest engine ideas.
What do you think?
Related ideas you can explore free:
killed: CosMe App by the Skin Health Institute (Australia) is the exact product — built by dermatologists, distributed through the Allergy Life patient network, with patch-test clinical trial provenance a startup cannot replicate. The claim that no consumer app does personal-profile matching from patch tests was factually wrong as of 2025–2026.
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.